<DOC>
	<DOCNO>NCT02423122</DOCNO>
	<brief_summary>This study assess effect administration VX-745 12 week amyloid plaque burden Alzheimer 's disease ( AD ) . Subjects meet entry criterion undergo 11C-PiB ( Carbon-11-labeled Pittsburgh Compound B ) positron emission tomography ( PET ) baseline 45 day dose VX-745 . Cognitive test also conduct baseline day 45 .</brief_summary>
	<brief_title>A PET Study Effects p38 MAP Kinase Inhibitor , VX-745 , Amyloid Plaque Load Alzheimer 's Disease ( AD )</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<mesh_term>Plaque , Amyloid</mesh_term>
	<criteria>Willing able provide inform consent Diagnosis mild cognitive impairment ( MCI ) due probable AD mild AD MMSE range : 20 28 Evidence amyloid pathology amyloid PET scan Participants may take medication AD , provide dose medication stable &gt; 3 month Proficiency Dutch adequate visual auditory ability able perform aspect cognitive functional test Adequate visual auditory ability perform aspect cognitive functional assessment . Evidence neurodegenerative disease AD Inability reason undergo PET fMRI scan ( include notably : history allergic reaction severity 11CPiB injection ; pacemaker , vascular stent stent graft ) Psychiatric disorder would compromise ability comply study requirement Significant cardiovascular , pulmonary , renal , liver , infectious disease , immune disorder metabolic/endocrine disorder disease would preclude treatment p38 MAP kinase inhibitor and/or assessment drug safety efficacy Recent ( &lt; 90 day ) change AD medication prescribe cognitive reason potential impact cognition Participation study investigational drug le 6 month 5 halflives investigational drug , whichever longer , enrollment study Male subject female partner childbearing potential unwilling unable adhere contraception requirement Female subject reach menopause hysterectomy bilateral oophorectomy/salpingoophorectomy Positive urine serum pregnancy test plan desire become pregnant course trial Any factor deem investigator likely interfere study conduction</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>